SpectraCure Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for SpectraCure.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 23.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
We're Hopeful That SpectraCure (STO:SPEC) Will Use Its Cash Wisely
Feb 23
We're Not Very Worried About SpectraCure's (STO:SPEC) Cash Burn Rate
Nov 09Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth
Jul 27Companies Like SpectraCure (STO:SPEC) Are In A Position To Invest In Growth
Mar 09SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans
Nov 08SpectraCure (STO:SPEC) Is In A Good Position To Deliver On Growth Plans
Jul 26We Think SpectraCure (STO:SPEC) Can Afford To Drive Business Growth
Mar 19Here's Why We're Not Too Worried About SpectraCure's (STO:SPEC) Cash Burn Situation
Nov 16We Think SpectraCure (STO:SPEC) Can Easily Afford To Drive Business Growth
Aug 03We're Not Worried About SpectraCure's (STO:SPEC) Cash Burn
Apr 16Companies Like SpectraCure (STO:SPEC) Can Afford To Invest In Growth
Jan 01In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SpectraCure has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 0 | -20 | -34 | -19 | N/A |
| 9/30/2023 | N/A | -23 | -36 | -21 | N/A |
| 6/30/2023 | N/A | -23 | -37 | -22 | N/A |
| 3/31/2023 | N/A | -24 | -37 | -22 | N/A |
| 12/31/2022 | 1 | -25 | -33 | -23 | N/A |
| 9/30/2022 | N/A | -25 | -32 | -23 | N/A |
| 6/30/2022 | N/A | -25 | -29 | -20 | N/A |
| 3/31/2022 | N/A | -25 | -30 | -23 | N/A |
| 12/31/2021 | N/A | -23 | -27 | -19 | N/A |
| 9/30/2021 | 1 | -22 | -22 | -13 | N/A |
| 6/30/2021 | 1 | -19 | -25 | -16 | N/A |
| 3/31/2021 | 1 | -16 | -21 | -10 | N/A |
| 12/31/2020 | 1 | -15 | -20 | -9 | N/A |
| 9/30/2020 | 1 | -15 | -26 | -14 | N/A |
| 6/30/2020 | 1 | -15 | -15 | -12 | N/A |
| 3/31/2020 | 1 | -15 | -25 | -10 | N/A |
| 12/31/2019 | 1 | -14 | -25 | -10 | N/A |
| 9/30/2019 | 1 | -16 | -32 | -13 | N/A |
| 12/31/2018 | 1 | -13 | -24 | -12 | N/A |
| 9/30/2018 | 1 | -9 | -15 | -8 | N/A |
| 12/31/2017 | 3 | -9 | 2 | 6 | N/A |
| 9/30/2017 | 3 | -8 | N/A | -6 | N/A |
| 6/30/2017 | 3 | -7 | N/A | -7 | N/A |
| 3/31/2017 | 3 | -7 | N/A | -7 | N/A |
| 12/31/2016 | 3 | -6 | N/A | -20 | N/A |
| 9/30/2016 | 3 | -7 | N/A | -8 | N/A |
| 6/30/2016 | 2 | -7 | N/A | -2 | N/A |
| 3/31/2016 | 2 | -7 | N/A | N/A | N/A |
| 12/31/2015 | 1 | -6 | N/A | -10 | N/A |
| 9/30/2015 | 1 | -6 | N/A | N/A | N/A |
| 6/30/2015 | 1 | -6 | N/A | N/A | N/A |
| 3/31/2015 | 1 | -4 | N/A | N/A | N/A |
| 12/31/2014 | 1 | -4 | N/A | -1 | N/A |
| 12/31/2013 | 1 | -6 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SPEC's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if SPEC's earnings are forecast to grow faster than the Swedish market
High Growth Earnings: Insufficient data to determine if SPEC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if SPEC's revenue is forecast to grow faster than the Swedish market.
High Growth Revenue: Insufficient data to determine if SPEC's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SPEC's Return on Equity is forecast to be high in 3 years time